Alexei V Tumanov Selected Research

Lymphotoxin-alpha (Lymphotoxin)

1/2021	Metabolic activation and colitis pathogenesis is prevented by lymphotoxin β receptor expression in neutrophils.
1/2018	Lymphotoxin in physiology of lymphoid tissues - Implication for antiviral defense.
1/2018	Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammation.
10/2012	Lymphotoxin regulates commensal responses to enable diet-induced obesity.
3/2011	Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner.
10/2009	Accelerated thymic atrophy as a result of elevated homeostatic expression of the genes encoded by the TNF/lymphotoxin cytokine locus.
2/2004	SMUCKLER/TIM4 is a distinct member of TIM family expressed by stromal cells of secondary lymphoid tissues and associated with lymphotoxin signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexei V Tumanov Research Topics

Disease

8	Infections 01/2022 - 03/2010
5	Inflammation (Inflammations) 01/2020 - 11/2016
3	Neoplasms (Cancer) 01/2021 - 05/2010
2	Pain (Aches) 01/2022 - 01/2021
2	Hypersensitivity (Allergy) 01/2021 - 02/2004
2	Asthma (Bronchial Asthma) 01/2019 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2017
2	Ischemia 07/2017 - 11/2016
1	Scrub Typhus (Typhus, Scrub) 01/2022
1	Colitis 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Ganglion Cysts (Ganglion) 01/2021
1	Campylobacter Infections (Campylobacter Infection) 01/2020
1	Intestinal Diseases (Diseases, Intestinal) 01/2020
1	Splenomegaly 01/2018
1	Eosinophilia 01/2018
1	Reperfusion Injury 07/2017
1	Atherosclerosis 11/2016
1	Necrotizing Enterocolitis 11/2016
1	Thrombosis (Thrombus) 11/2016
1	Wounds and Injuries (Trauma) 11/2016
1	Hypotension (Low Blood Pressure) 11/2016
1	Virus Diseases (Viral Diseases) 05/2015
1	Vesicular Stomatitis 05/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2014
1	Bacterial Pneumonia 05/2014
1	Plague (Bubonic Plague) 05/2014
1	Obesity 10/2012
1	Thinness 10/2012
1	Fibrosarcoma 03/2011
1	Carcinogenesis 05/2010
1	Bacterial Infections (Bacterial Infection) 03/2010
1	Atrophy 10/2009
1	Dyslipidemias (Dyslipidemia) 04/2007
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2006
1	Tertiary Lymphoid Structures 09/2006
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2006
1	Septic Shock (Toxic Shock Syndrome) 01/2005

Drug/Important Bio-Agent (IBA)

7	Lymphotoxin-alpha (Lymphotoxin)IBA 01/2021 - 02/2004
6	Lymphotoxin beta ReceptorIBA 01/2021 - 09/2006
5	CytokinesIBA 01/2019 - 09/2006
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2005
2	LigandsIBA 03/2011 - 05/2010
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022
1	ProlactinIBA 01/2022
1	pegvisomant FDA LinkGeneric 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Pituitary HormonesIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Interleukin-23 (Interleukin 23)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Neutralizing AntibodiesIBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Immunoglobulin E (IgE)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018
1	Superoxides (Superoxide)IBA 07/2017
1	ceric oxide (cerium dioxide)IBA 07/2017
1	EuropiumIBA 07/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2017
1	Tumor Biomarkers (Tumor Markers)IBA 01/2017
1	Antiviral Agents (Antivirals)IBA 05/2015
1	Interferon Type IIBA 05/2015
1	B-Cell Activation Factor ReceptorIBA 05/2015
1	Choline (Choline Chloride)IBA 10/2014
1	PerforinIBA 05/2014
1	VaccinesIBA 05/2014
1	Lipase (Acid Lipase)FDA Link 01/2013
1	Interleukin-22 (IL-22)IBA 07/2011
1	Fas Ligand Protein (Fas Ligand)IBA 05/2010
1	Member 3 Group F Nuclear Receptor Subfamily 1IBA 03/2010
1	ChemokinesIBA 03/2010
1	LDL Receptors (LDL Receptor)IBA 04/2007
1	LipidsIBA 04/2007
1	Proteins (Proteins, Gene)FDA Link 04/2007

Therapy/Procedure

2	Therapeutics 01/2019 - 05/2010
2	Transplantation 11/2016 - 10/2012
1	Biological Therapy 01/2019
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2006